Skip to main content

Nonprofit · EIN 13-3223946

NATIONAL ORGANIZATION FOR RARE DISORDERS INC

Tax-exempt · DANBURY, CT 06810

Financials

$66.4M$52.8M2023$50.7M$43M2024$34.6M$40.4M2025
Revenue Expenses · by fiscal year end
Financials of NATIONAL ORGANIZATION FOR RARE DISORDERS INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$34,577,196$40,401,111-$5,823,915$66,900,297$3,268,208$63,632,089
December 31, 2024990$50,676,798$43,034,462$7,642,336$72,321,740$3,745,803$68,575,937
December 31, 2023990$66,397,453$52,832,739$13,564,714$65,154,464$4,533,021$60,621,443
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$23,944,805
of which government grants
$1,172,580
Membership dues
$1,808,455
Program service revenue
$7,935,317
Investment income
$2,697,074
Net gain from sales of assets
$46,838
Other revenue
$0

Expenses

Grants and similar amounts paid
$22,081,890
Compensation of officers, directors and key employees
$1,110,324
Other salaries and wages
$8,884,911
Salaries, compensation and benefits (total)
$12,244,648
Professional fundraising fees
$0
Legal fees
$465,611
Accounting fees
$82,022
Occupancy
$458,499
Travel
$77,846
Depreciation
$1,126,877
Program services (functional)
$32,777,209
Management and general (functional)
$3,918,660
Fundraising (functional)
$3,705,242

Balance sheet and other

Total assets, start of year
$72,321,740
Total assets, end of year
$66,900,297
Total liabilities, end of year
$3,268,208
Net assets, end of year
$63,632,089
Land, buildings and equipment
$1,895,499
Publicly traded securities
$47,633,554
Net assets without donor restrictions
$10,464,343
Net assets with donor restrictions
$53,167,746
Gross receipts
$43,838,797
Employees
116
Volunteers
1,308
Year formed
1983
State of legal domicile
NY

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
PAMELA GAVINCEO
Trustee or director, Officer
35$479,961$32,088
EDWARD NEILANCHIEF MEDICAL & SCIENTIFIC OFFICER
Highest-paid employee
35$270,662$60,560
KELLEEN ESPERIASCHIEF STRATEGY & OPERATIONS OFFICER
Officer
35$294,239$29,613
PRASHANT GOELVP INFORMATION TECHNOLOGY
Highest-paid employee
35$293,256$15,368
ALEXANDRA MOOREVP OF DEVELOPMENT
Highest-paid employee
35$254,340$12,713
NEETA KOTECHAVP & CFO
Officer
35$186,375$38,387
TRACEY SIKORAVP OF RESEARCH & CLINICAL PROGRAMS
Highest-paid employee
35$194,233$24,588
JILL POLLANDERVP PATIENT SERVICES
Highest-paid employee
35$187,802$24,142
PETER SALTONSTALLSENIOR ADVISOR & CEO EMERITUS
Officer
17$47,303$2,358
KATHLEEN HOLCOMBECHAIR
Trustee or director, Officer
10$0$0
DENNIS JACKMANVICE CHAIR
Trustee or director, Officer
5$0$0
MARK SKINNERTREASURER
Trustee or director, Officer
5$0$0
LORNA WEIRSECRETARY
Trustee or director, Officer
5$0$0
KIM ISENBERGDIRECTOR
Trustee or director
1$0$0
PAUL LYONSDIRECTOR
Trustee or director
1$0$0
9 more people on this return
NameTitleHours / weekCompensation
SUSAN BERRY MDDIRECTOR
Trustee or director
1$0
SHAFALI JESTE MDDIRECTOR (UNTIL 12/2025)
Trustee or director
1$0
PHILIP PEARL MDDIRECTOR (UNTIL 12/2025)
Trustee or director
1$0
MIKE PORATHDIRECTOR
Trustee or director
1$0
TOM KELLYDIRECTOR
Trustee or director
1$0
STEVEN MAH PHDDIRECTOR
Trustee or director
1$0
ALAN MILLER MD PHDDIRECTOR
Trustee or director
1$0
SHELDON SCHUSTER PHDDIRECTOR
Trustee or director
1$0
JIM PALMADIRECTOR (UNTIL 12/2025)
Trustee or director
1$0
990 for the year ended December 31, 2024: 21 people
NameTitleHours / weekCompensationOther / benefits
PAMELA GAVINEVP (UNTIL 5/24)/CEO (AS OF 5/24)
Officer
35$441,759$33,733
PETER SALTONSTALLCEO (UNTIL 5/24)/CEO EMERITUS (AS OF 5/24)
Trustee or director, Officer
35$374,441$24,515
EDWARD NEILANCHIEF MEDICAL & SCIENTIFIC OFFICER
Highest-paid employee
35$270,662$61,615
PRASHANT GOELVP INFORMATION TECHNOLOGY
Highest-paid employee
35$283,442$14,622
PATRICK COLLINSVP COMMUNITY & CORPORATE AFFAIRS
Highest-paid employee
35$207,141$58,445
ALEXANDRA MOOREVP OF DEVELOPMENT
Highest-paid employee
35$245,775$12,284
NEETA KOTECHAVP & CFO
Officer
35$179,637$42,329
JILL POLLANDERVP PATIENT SERVICES
Highest-paid employee
35$182,382$25,766
KELLEEN ESPERIASCHIEF STRATEGY & OPERATIONS OFFICER
Officer
35$71,108$6,327
KATHLEEN HOLCOMBECHAIR
Trustee or director, Officer
10$0$0
SHELDON SCHUSTER PHDVICE CHAIR
Trustee or director, Officer
5$0$0
LEON EIDELMANTREASURER (UNTIL 12/24)
Trustee or director, Officer
5$0$0
JIM PALMASECRETARY
Trustee or director, Officer
5$0$0
DENNIS JACKMANDIRECTOR
Trustee or director
1$0$0
MARK SKINNERDIRECTOR
Trustee or director
1$0$0
SUSAN BERRY MDDIRECTOR
Trustee or director
1$0$0
SHAFALI JESTE MDDIRECTOR
Trustee or director
1$0$0
PHILLIP PEARL MDDIRECTOR
Trustee or director
1$0$0
MIKE PORATHDIRECTOR
Trustee or director
1$0$0
TOM KELLYDIRECTOR
Trustee or director
1$0$0
LORNA WEIRDIRECTOR
Trustee or director
1$0$0
990 for the year ended December 31, 2023: 21 people
NameTitleHours / weekCompensationOther / benefits
PETER SALTONSTALLPRESIDENT/CEO
Trustee or director, Officer
35$496,804$26,404
PAMELA GAVINEXECUTIVE VICE PRESIDENT
Officer
35$390,823$31,910
EDWARD NEILANCHIEF MEDICAL & SCIENTIFIC OFFICER
Highest-paid employee
35$270,662$58,975
PRASHANT GOELVP INFORMATION TECHNOLOGY
Highest-paid employee
35$282,667$14,531
ALEXA MOOREVP OF DEVELOPMENT
Highest-paid employee
35$235,028$11,747
LISA SARFATYVP COMMUNITY ENGAGEMENT
Highest-paid employee
35$173,427$54,480
NEETA KOTECHAVP FINANCE
Officer
35$177,102$38,575
JILL POLLANDERVP PATIENT SERVICES
Highest-paid employee
35$179,475$23,972
KATHLEEN HOLCOMBECHAIR
Trustee or director, Officer
10$0$0
DENNIS JACKMANVICE CHAIR
Trustee or director, Officer
1$0$0
LEON EIDELMANTREASURER
Trustee or director, Officer
5$0$0
JIM PALMASECRETARY
Trustee or director, Officer
1$0$0
MARK SKINNERDIRECTOR
Trustee or director
5$0$0
SUSAN BERRY MDDIRECTOR
Trustee or director
1$0$0
SHAFALI JESTE MDDIRECTOR
Trustee or director
1$0$0
PHILLIP PEARL MDDIRECTOR
Trustee or director
1$0$0
MIKE PORATHDIRECTOR
Trustee or director
1$0$0
TOM KELLYDIRECTOR (AS OF 5/4/23)
Trustee or director
1$0$0
SHELDON SCHUSTER PHDDIRECTOR (AS OF 5/4/23)
Trustee or director
1$0$0
LORNA WEIRDIRECTOR (AS OF 5/4/23)
Trustee or director
1$0$0
STEVEN GROSSMANDIRECTOR (UNTIL 1/31/23)
Trustee or director
1$0$0

Address and contacts

Address (IRS master file)
7 KENOSIA AVENUE, DANBURY, CT 06810-7395
Principal officer (990 for 2025)
NEETA KOTECHA, 120 LONGWATER DRIVE 105, NORWELL, MA 02061
Signed the 990
NEETA KOTECHA, VP AND CHIEF FINANCIAL OFFICER
Phone
(617) 249-7300
Return prepared by
AAFCPAS INC

Mission

NORD STRIVES TO IMPROVE THE HEALTH AND WELL-BEING OF PEOPLE WITH RARE DISEASES BY DRIVING ADVANCES IN CARE, RESEARCH, AND POLICY.

990 for the year ended December 31, 2025

Program accomplishments

  • NORD'S PATIENT ASSISTANCE PROGRAMS PROVIDE ELIGIBLE INDIVIDUALS WITH FINANCIAL ASSISTANCE TO SUPPORT THE BROAD RANGE OF CARE AND TREATMENT NEEDS ASSOCIATED WITH MANAGING A RARE DISEASE. EACH DISEASE-SPECIFIC PROGRAM IS DESIGNED TO ADDRESS THE NUANCES OF THE INDIVIDUAL CONDITION AND THE UNIQUE NEEDS OF ITS PATIENT COMMUNITY. ASSISTANCE MAY INCLUDE SUPPORT FOR HEALTH INSURANCE PREMIUMS, COPAYMENTS, AND COINSURANCE, AS WELL AS CERTAIN COVERED OUT-OF-POCKET MEDICAL EXPENSES. NORD'S APPROACH ENSURES THAT ELIGIBLE INDIVIDUALS, WHETHER COMMERCIALLY INSURED, PUBLICLY INSURED, UNDERINSURED, OR UNINSURED, RECEIVE THE FINANCIAL SUPPORT NECESSARY TO ACCESS THE CARE AND TREATMENT PRESCRIBED BY THEIR HEALTH CARE PROVIDER(S). IN 2025, NORD'S PATIENT ASSISTANCE PROGRAMS PROVIDED FINANCIAL ASSISTANCE TO 6,880 INDIVIDUALS, INCLUDING 6,602 INDIVIDUALS SUPPORTED THROUGH OUR PAP AND 278 INDIVIDUALS WHO RECEIVED TRAVEL AND LODGING ASSISTANCE TO PARTICIPATE IN CLINICAL TRIALS.
    Expenses $25,200,680 · grants $22,081,890 · revenue $4,936,057
  • NORD'S EDUCATIONAL INITIATIVES STRIVE TO EMPOWER PATIENTS AND THEIR FAMILIES, INFORM AND EDUCATE STUDENTS ACROSS DISCIPLINES FROM HIGH SCHOOL THROUGH GRADUATE SCHOOL, AND SUPPORT THE VITALLY IMPORTANT WORK OF PHYSICIANS AND OTHER HEALTHCARE PROFESSIONALS IN IMPROVING THE RECOGNITION OF SYMPTOMS OF RARE DISEASE AND EARLY, ACCURATE DIAGNOSIS AS WELL AS IMPROVING CLINICIAN KNOWLEDGE AND COMPETENCE IN TREATING RARE DISEASES. THIS IS DONE THROUGH THE DEVELOPMENT OF NORD'S RARE DISEASE DATABASE OF MORE THAN 1,480 COMPREHENSIVE EXPERT-WRITTEN REPORTS ON SPECIFIC RARE DISORDERS, THE DELIVERY OF RARE DISEASE VIDEOS AND WEBINARS, AND THROUGH ROBUST EDUCATIONAL PROGRAMMING WITH NORD'S CME PROGRAM AND AT THE NORD RARE DISEASES AND ORPHAN PRODUCTS BREAKTHROUGH SUMMIT. IN 2025, 759 PEOPLE ATTENDED THE NORD SUMMIT IN PERSON, AND 60 PEOPLE REGISTERED TO ATTEND VIRTUALLY. ALSO, IN 2025, THERE WERE OVER 15 MILLION VISITORS TO NORD'S RARE DISEASE DATABASE.
    Expenses $1,921,195 · revenue $2,046,711
  • IN 2025, NORD CONTINUED TO ADVANCE THE IAMRARE NATURAL HISTORY AND REGISTRY PLATFORM TO STRENGTHEN RARE DISEASE RESEARCH AND IMPROVE THE PATIENT EXPERIENCE IN SUPPORT OF THERAPEUTIC DEVELOPMENT. MAJOR PLATFORM ENHANCEMENTS INCLUDED THE LAUNCH OF A REDESIGNED UI TO STREAMLINE NAVIGATION AND IMPROVE CROSS-BROWSER CONSISTENCY, AND THE RELEASE OF THE IAMRARE MOBILE APP WITH FEATURES SUCH AS PUSH NOTIFICATIONS FOR SURVEY REMINDERS AND DEVICE-LEVEL ACCESSIBILITY CONTROLS. AS OF DECEMBER 2025, THERE WERE 22,142 CONSENTED PARTICIPANTS ACROSS 51 REGISTRIES. IN ADDITION, DURING 2025, 10 NEW RARE DISEASE REGISTRIES WERE LAUNCHED, REPRESENTING THE LARGEST NUMBER INITIATED IN A SINGLE YEAR, AND THE RESEARCH TEAM WAS SUPPORTING THE DEVELOPMENT OF 24 ADDITIONAL REGISTRIES.
    Expenses $3,000,676 · revenue $952,549
  • THE NATIONAL ORGANIZATION FOR RARE DISORDERS ENGAGES IN ADVOCACY EFFORTS THAT SERVE AS A LIAISON BETWEEN THE RARE DISEASE COMMUNITY AND THE ORGANIZATIONS AND INSTITUTIONS THAT HAVE A DIRECT IMPACT ON THE LIVES OF THE APPROXIMATELY 30 MILLION AMERICANS LIVING WITH RARE DISEASES. NORD WORKS WITH A WIDE RANGE OF STAKEHOLDERS, INCLUDING STATE AND FEDERAL AGENCIES AND LEGISLATORS, NONPROFIT ORGANIZATIONS, AND PRIVATE SECTOR PARTNERS TO RAISE AWARENESS OF THE NEEDS OF RARE DISEASE PATIENTS AND TO ADVANCE POLICIES AND INITIATIVES THAT IMPROVE CARE, TREATMENT, AND SUPPORT FOR THE RARE DISEASE COMMUNITY.
    Expenses $1,085,277
  • THE NATIONAL ORGANIZATION FOR RARE DISORDERS IS THE LEADING RARE DISEASE UMBRELLA ORGANIZATION IN THE UNITED STATES, PROVIDING ITS MEMBER ORGANIZATIONS WITH SUPPORT IN ADVOCACY, EDUCATION, RESEARCH, PROFESSIONAL DEVELOPMENT, ORGANIZATIONAL LEADERSHIP, AND COMMUNICATIONS. THROUGH THESE PROGRAMS AND SERVICES, NORD EQUIPS LEADERS OF PATIENT ORGANIZATIONS WITH THE TOOLS AND RESOURCES NEEDED TO REMAIN INFORMED, CONNECTED, AND EFFECTIVE AS THEY ESTABLISH, GROW, AND STRENGTHEN THEIR ORGANIZATIONS. AS OF DECEMBER 2025, NORD SUPPORTED 360 MEMBER PATIENT ORGANIZATIONS.
    Expenses $649,212
  • THE NORD RARE DISEASE CENTERS OF EXCELLENCE PROGRAM IDENTIFIES AND COLLABORATES WITH A NETWORK OF U.S. MEDICAL INSTITUTIONS THAT HAVE EXCEPTIONAL CLINICAL AND RESEARCH PROGRAMS SERVING PATIENTS WITH RARE DISEASES. THESE INSTITUTIONS WORK IN PARTNERSHIP WITH NORD, WITH ONE ANOTHER, AND WITH THEIR LOCAL COMMUNITIES OF PHYSICIANS, CAREGIVERS, AND PATIENTS TO SHARE EXPERT KNOWLEDGE, DEFINE STANDARDS OF PRACTICE FOR RARE DISEASES, ACCELERATE DIAGNOSIS, AND IMPROVE PATIENT CARE, TREATMENT, AND RESEARCH. THROUGH THIS COLLABORATIVE NETWORK, THE PROGRAM HELPS ADVANCE BEST PRACTICES AND IMPROVE OUTCOMES FOR INDIVIDUALS LIVING WITH RARE DISEASES. AS OF DECEMBER 2025, THERE WERE 46 DESIGNATED RARE DISEASE CENTERS OF EXCELLENCE.
    Expenses $920,169

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
13-3223946
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1989
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$66,900,297
Income (IRS master file)
$43,838,797

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$34,577,196$40,401,111$66,900,297XML
990December 2024$50,676,798$43,034,462$72,321,740XML
990December 2023$66,397,453$52,832,739$65,154,464XML
990December 2022$59,872,383$48,420,739$49,542,120IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 13-3223946).

Questions about NATIONAL ORGANIZATION FOR RARE DISORDERS INC

What is the EIN of NATIONAL ORGANIZATION FOR RARE DISORDERS INC?
The employer identification number (EIN) of NATIONAL ORGANIZATION FOR RARE DISORDERS INC is 13-3223946.
Is NATIONAL ORGANIZATION FOR RARE DISORDERS INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1989.
Are donations to NATIONAL ORGANIZATION FOR RARE DISORDERS INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does NATIONAL ORGANIZATION FOR RARE DISORDERS INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of NATIONAL ORGANIZATION FOR RARE DISORDERS INC due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did NATIONAL ORGANIZATION FOR RARE DISORDERS INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of NATIONAL ORGANIZATION FOR RARE DISORDERS INC?
The 990 for the year ended December 31, 2025 names NEETA KOTECHA.
Who are the officers and directors of NATIONAL ORGANIZATION FOR RARE DISORDERS INC?
The 990 for the year ended December 31, 2025 lists 24 people; 9 received compensation from the organization, the highest $479,961 (PAMELA GAVIN, CEO).
How much revenue does NATIONAL ORGANIZATION FOR RARE DISORDERS INC have?
On its 990 for the year ended December 31, 2025 it reported revenue of $34,577,196, expenses of $40,401,111 and total assets of $66,900,297 at year end.

Other nonprofits in DANBURY

All nonprofits in DANBURY · Connecticut